Login to Your Account



Advent Venture Closes $120M Dedicated Life Sciences Fund

By Nuala Moran


Wednesday, December 1, 2010
LONDON – At a time when venture capital funding for early stage companies is increasingly hard to come by, Advent Venture Partners has brought some cheer with the final closing at £75 million (US$120 million) of its first dedicated life sciences fund. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription